The inflammasome is a macromolecular protein complex that mediates proteolytic cleavage of pro-IL-1 and -IL-18 and induces cell death in the form of pyroptosis. Certain nucleotidebinding oligomerization domain-like receptors (NLRs), absent in melanoma 2 (AIM2)-like receptors (ALRs), or tripartite motif (TRIM) family receptors trigger the assembly of an inflammasome in response to pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs). Recent studies have revealed a multitude of host components and signals that are essential for controlling canonical and noncanonical inflammasome activation and pyroptosis.
INTRODUCTION
The inflammasome is a cytosolic multimeric signaling complex that coordinates host immune responses to invading pathogens and hostderived danger signals. Formation of the inflammasome is initiated by cytosolic PRRs, which are innate immune sensors capable of recognizing PAMPs and DAMPs. Whereas there are many families of PRRs, Abbreviations: -H2AX, -H2A histone family member X; AIM2, absent in melanoma 2; ALR, absent in melanoma 2-like receptor; ASC, apoptosis-associated speck-like protein containing a caspase activation and recruitment domain; BMDM, bone marrow-derived macrophage; BRCC, BRCA1-BRCA2-containing complex; CARD, C-terminal caspase activation and recruitment domain; Cas, clustered regularly interspaced short palindromic repeat-associated system; cGAS, cyclic GMP-AMP synthase; DAMP, danger-associated molecular pattern; DC, dendritic cell; DPP, dipeptidyl peptidase; DSS, dextran sodium sulfate; DUB, deubiquitinase; FBXL2, F-box/leucine-rich repeat protein 2; FIIND, function-to-find domain; FMF, familial Mediterranean fever; GBP, guanylate-binding protein; HIN, hematopoietic expression; IAV, influenza A virus; IFI, IFN--inducible protein; IFNAR, IFN-/ receptor; IRAK, IL-1 receptor-associated kinase; IRF, IFN regulatory factor; IRG, immunity-related GTPase; LRR, leucine-rich repeat; MEFV, Mediterranean fever; MLKL, mixed lineage kinase domain-like protein; mtDNA, mitochondrial DNA; NAIP, nucleotide-binding oligomerization domain-like receptor family apoptosis inhibitory protein 1; NBD, nucleotide-binding domain; NEK7, never in mitosis A-related kinase 7; NLR, nucleotide-binding oligomerization domain-like receptor; P2X7R, P2X purinoceptor 7; PAAND, Pyrin-associated autoinflammation with neutrophilic dermatosis; PAMP, pathogen-associated molecular pattern; PKC, protein kinase C; PKN, serine/threonine protein kinase N; POP, Pyrin domain-only protein; PRR, pattern recognition receptor; PYD, Pyrin domain; RIPK, receptor-interacting serine/threonine protein kinase; ROS, reactive oxygen species; STING, stimulator of IFN genes; T3SS, type 3 secretion systems; TRIF, Toll/IL-1R domain-containing adaptor-inducing IFN-; TRIM, tripartite motif those known to form inflammasome complexes include members of the NLRs, ALRs, and the TRIM family member, Pyrin. The presence of multiple cytosolic PRRs, capable of forming an inflammasome, enables the host to respond to diverse stimuli. NLRP1 was first described to form an inflammasome complex in 2002, 1 sparking intense interest to determine which other PRRs might also form inflammasome complexes. Since then, NLRP3, NLRC4, AIM2, and Pyrin have also been shown to form inflammasome complexes; 2 whereas less thoroughly characterized, there is also evidence that human NLRP2, NLRP7, and IFI16 and mouse NLRP6, NLRP9b, and NLRP12 can activate caspase-1. 3 In most cases, activated PRRs bind and engage the inflammasome adaptor protein ASC to recruit and activate the cysteine protease caspase-1. 4 ASC is a bipartite protein consisting of an N-terminal PYD and a CARD. Following PRR activation, ASC rapidly oligomerizes through homotypic PYD-PYD interactions into a large filamentous scaffold. 5, 6 Inactive procaspase-1 monomers are recruited to ASC filaments through CARD-CARD interactions and thereby, brought into close proximity for optimal self-activation. 5, 6 This sensor-ASC-caspase-1 inflammasome complex can be visualized as a distinct "speck" of 0.8-1 µm in diameter within the cytoplasm of macrophages and DCs; 7-10 indeed, formation of a speck is considered characteristic of inflammasome assembly. 11 Inflammasome specks released from pyroptotic cells have even been found to act as DAMPs and amplify the inflammatory response. 12, 13 After recruitment to the inflammasome complex and undergoing self-activation, caspase-1 executes several key cellular functions that are characteristic hallmarks of inflammasome activation. Caspase-1 proteolytically processes the proinflammatory cytokines pro-IL-1 and pro-IL-18 into their biologically active forms. In addition, caspase-1 cleaves the propyroptotic factor gasdermin D. [14] [15] [16] The N-terminal fragment of gasdermin D oligomerizes and forms pores on the host cell membrane, [17] [18] [19] [20] [21] 
NLRP1 INFLAMMASOME
Human NLRP1 was the first protein identified to form an inflammasome complex. 1 This inflammasome complex contains NLRP1, ASC, and caspase-1 and -5. 1 The human NLRP1 protein is composed of a PYD, NBD, LRR, FIIND, and CARD. 1 Unlike human NLRP1, mice carry 3 NLRP1 paralogs (Nlrp1a, -b, and -c), all of which lack a PYD. 22 Mouse Nlrp1b and rat Nlrp1 are activated by the anthrax lethal toxin secreted by Bacillus anthracis. 23, 24 The protective antigen component of the toxin transports the lethal factor component into the host cell, where the lethal factor induces N-terminal proteolytic cleavage of mouse Nlrp1b and rat Nlrp1 to catalyze the activation of the NLRP1 inflammasome [23] [24] [25] (Fig. 1) . Mouse Nlrp1a is also activated by N-terminal proteolytic cleavage. 26 Likewise, human NLRP1 undergoes proteolysis within a specific N-terminal linker region between the PYD and NBD. 26 The observation that any protease capable of inducing site-specific N-terminal proteolytic cleavage is sufficient to activate the NLRP1 inflammasome suggests that proteolysis is a conserved mechanism of NLRP1 inflammasome activation in rodents and primates.
Owing to the presence of a CARD, mouse Nlrp1b licenses activation of caspase-1, secretion of IL-1 , and induction of pyroptosis in murine macrophages stimulated with lethal toxin in an ASCindependent manner. 27,28 However, ASC is required to amplify secretion of IL-1 in response to low-dose lethal toxin 27 (Fig. 1 ). Mice bear a susceptible and resistant form of Nlrp1b, 22 and those carrying a susceptible variant are protected against B. anthracis infection as a result of the ability of the susceptible variant to respond to the lethal toxin compared with mice harboring a resistant form. 29,30 Whereas NLRP1 is best known for its role in sensing B. anthracis infection, it has also been implicated in the host response to the protozoan Toxoplasma gondii. For instance, mice deficient in Nlrp1b and Nlrp3 and infected with T. gondii produce less IL-1 and IL-18, harbor increased parasitic loads, and succumb to the infection. 31 These findings suggest that Nlrp1b, in association with another NLR, can synergistically mount an effective host response.
Several studies have unraveled the biochemical mechanisms regulating activation of the NLRP1 inflammasome. The FIIND of NLRP1 undergoes autoproteolytic cleavage at the S1213 residue. 32,33 Furthermore, studies using point mutations and structural analysis revealed that the H1186 residue, located within a loop proximal to the cleavage site of the FIIND of NLRP1, is essential for autoproteolytic cleavage. 32, 33 Mutagenesis studies targeting several residues within a fragment of Nlrp1b revealed that cleavage of the FIIND results in recruitment of procaspase-1. 34 Likewise, genetic disruption of the FIIND of Nlrp1b leads to impairment of self-oligomerization and activation of procaspase-1. 34 These studies demonstrate that cleavage of the FIIND contributes to activation of the Nlrp1b inflammasome.
Human NLRP1 is regulated by the autoinhibitory function of the PYD and LRR domains. 35 Mutations targeting the PYD (A54T, A66V, and M77T) or deletion of the PYD (aa 93-1474) or of residues in the LRR domain (F787-R843) promote increased production of IL-1 in immortalized keratinocytes. 35 These results suggest that the PYD and LRR domains maintain NLRP1 in an inactive conformation rather than facilitating ASC oligomerization. In humans, germline gain-of-function mutations in the PYD and LRR domains of NLRP1 predispose individuals to the skin diseases, multiple self-healing palmoplantar carcinoma and familial keratosis lichenoides chronica. 35 There is evidence to indicate that the NLRP1 paralog Nlrp1a has inflammasome functions. A single point mutation, causing a glutamineto-proline substitution at aa 593 of Nlrp1a (Nlrp1a Q593P ), induces a systemic inflammatory disease in mice. 36 This inflammatory phenotype is prevented by genetic deletion of caspase-1, IL-1 , or IL-1R but not ASC, 36 implicating a role for Nlrp1a in assembling an Nlrp1a-caspase-1 complex, driving IL-1 -mediated immunopathology. Spontaneous caspase-1 activation induced by the Nlrp1a Q593P mutation results in pyroptosis of myeloid progenitor cells that affects their capacity to differentiate into mature myeloid cells. 36 The physiologic relevance of Nlrp1a has been examined in the context of infectious disease. The Nlrp1a Q593P Il1r −/− mouse strain, which does not develop systemic inflammation, suffers from prolonged cytopenia, bone marrow hypoplasia, and immunosuppression in response to lymphocytic choriomeningitis virus infection. 36 Further studies are required to decipher the differential roles of the 3 paralogs of Nlrp1 in mice. Whereas there has been progress in dissecting the molecular mechanisms contributing to the activation of the NLRP1 inflammasome, more comprehensive studies are required to understand fully its role in infection and autoinflammatory diseases.
CANONICAL NLRPINFLAMMASOME
NLRP3 is known as a global sensor of PAMPs and DAMPs as a result of its ability to form an inflammasome in response to diverse PAMPs and DAMPs cause physiologic aberrations in the cell, which manifest in the forms of ion efflux and influx, mitochondrial dysfunction, or rupture of the phagosome. 63, 64, 66, 67, [69] [70] [71] [72] 74, 75 These physiologic alterations are sensed by NLRP3, which induces the assembly of the NLRP3 inflammasome mediated by the kinase NEK7, ASC, and caspase-1. [79] [80] [81] Caspase-1 cleaves gasdermin D, releasing the N-terminal fragment of gasdermin D that assembles into pores on the membrane, resulting in pyroptosis. [14] [15] [16] Active caspase-1 also cleaves pro-IL-1 and pro-IL-18, which are secreted through the pores formed by gasdermin D. (B) The non-canonical NLRP3 inflammasome is specifically activated by Gram-negative bacteria. 133 LPS from Gram-negative bacteria is recognized by TLR4 via the adaptor TRIF, resulting in the production of type I IFNs. [151] [152] [153] Type I
IFNs induce the expression of IFIs GBPs and IRGB10 and caspase-11. 156, 158 GBPs rupture the pathogen-containing vacuole, causing aberrant release of the bacteria into the cytoplasm, 156 and both GBPs and IRGB10 are recruited to the bacteria to disrupt and kill the pathogen. 158 LPS can also be released into the cytoplasm via bacterial outer-membrane vesicles. 148 Liberated LPS binds to caspase-11, promoting oligomerization and activation of caspase-11. 138 Active caspase-11 cleaves gasdermin D to induce pyroptosis. [14] [15] [16] The N-terminal fragment of gasdermin D also induces activation of the NLRP3 inflammasome and secretion of IL-1 and IL-18 14, 15 The second signal, resulting in full activation of the NLRP3 inflammasome, is provided by an NLRP3 activator in the form of a PAMP or DAMP. 74 and modulation in cell volume. 75 Although potassium efflux was proposed to be the converging signal, 66 a pathway leading to the activation of the NLRP3 inflammasome that does not require potassium efflux has been observed. 68 Components of the NLRP3 inflammasome are localized to specific organelles; this subcellular localization has been proposed to govern activation of the inflammasome. A study demonstrated that NLRP3 activators induce translocation of ASC and NLRP3 from the mitochondria and endoplasmic reticulum, respectively, to the perinuclear region, where these components assemble an inflammasome complex. 67 A further study has shown that ASC migrates from the mitochondria to the endoplasmic reticulum, where NLRP3 residesa process assisted by motor proteins kinesin and dynein. 76 In this case, NLRP3 activators decrease intracellular concentration of nicotinamide adenine dinucleotide + , which leads to inactivation of tubulin deacetylase Sirtuin 2 and accumulation of acetylated -tubulin. 76 The accumulation of acetylated -tubulin drives ASC movement toward NLRP3, thereby facilitating inflammasome assembly. 76 A further study has suggested that localization of NLRP3 to the mitochondria requires interaction between the N-terminal residues of NLRP3 and the mitochondrial adaptor protein mitochondrial antiviral signaling. 77 The ability of NLRP3 to form oligomers and initiate prion-like nucleation allows rapid oligomerization of ASC to form larger polymers. 5, 6, 12, 13 Given that multiple models of the inflammasome complex have been proposed, 78 additional comparative structural analysis of endogenous proteins from cells stimulated with a range of activators would reveal all possible architectures of the inflammasome.
Progress has been made to identify further novel components of the NLRP3 inflammasome. Recent studies have shown that the kinase NEK7 is specifically required for the activation of the NLRP3 inflammasome [79] [80] [81] ( Fig. 2A) . Phosphorylated NEK7 binds to the LRR domain of NLRP3, 79, 80 suggesting that NEK7 may relieve autoinhibition of NLRP3. Overexpression studies revealed that NEK7 binds more strongly to NLRP3 carrying missense mutations associated with neonatal onset multisystem inflammatory disease compared with wildtype NLRP3. 79 Interaction between NEK7 and NLRP3 can be reduced by cytochrome C, 82 implying that the level of cytochrome C may drive the cell fate toward apoptosis rather than pyroptosis. inflammasome to mediate caspase-1 activation. 112 A link between the NLRP3 inflammasome and the necroptotic cell death pathway has emerged. In response to necroptotic activators, the kinase RIPK3 and the necroptotic effector MLKL are required to activate the NLRP3 inflammasome and induce IL-1 release. 113, 114 In this case, MLKL oligomerizes on the cell membrane to induce pore formation, resulting in necroptosis and a reduction in the level of intracellular potassium triggering activation of the NLRP3 inflammasome. 113, 114 Of particular interest is that MLKL-dependent secretion of IL-1 does not rely on the pyroptosis executor gasdermin D, 113, 114 suggesting that IL-1 might be released through MLKL-induced pores instead. These studies further accentuate the complex interplay between the NLRP3 inflammasome and nonpyroptotic cell death pathways.
Owing to the large number of stimuli that can activate NLRP3, posttranslational modifications exist at multiple levels to modulate and fine tune NLRP3 inflammasome activation. NLRP3 is maintained in its inactive form via binding of its LRR domain to the ubiquitin ligaseassociated protein suppressor of the G2 allele of skp1 (SGT1). 115 Likewise, NLRP3 is ubiquitinated and undergoes proteasomal degradation mediated by ubiquitin ligases S-phase kinase-associated protein 1-cullin-F-box protein and FBXL2. 116 FBXL2 binds to the W73 residue within the PYD and the K689 residue within the LRR domain of NLRP3
and further ubiquitinates at the K689 residue within the LRR domain of NLRP3. 116 In addition to NLRP3 expression being induced by the priming step, NLRP3 is post-translationally activated by deubiquitination, which is mediated by a DUB enzyme in both mice and humans. 117, 118 A later study clarified that activation of NLRP3 requires deubiquitination of its LRR domain by the DUB enzyme BRCC3 in mice or BRCC36 in human. 119 Furthermore, phosphorylation of residue Y144 and linear ubiquitination of ASC are required for the activation of the NLRP3 inflammasome. 120, 121 Further studies have shown that NLRP3 inflammasome is activated when the kinase Syk is phosphorylated in response to fungal, malarial, and mycobacterial pathogens. [122] [123] [124] [125] Mass spectrometry analysis revealed 3 corresponding conserved and phosphorylated serine residues in mouse (S3, S157, and S725) and human (S5, S161, and S728) NLRP3. 126 Mutation of the S5 residue located in the PYD of NLRP3 to a phosphomimetic aspartate (S5D) completely abolishes NLRP3-dependent ASC speck formation. 126 However, mutation of the other 2 serine sites had no effect on NLRP3 activity. 126 Furthermore, phosphorylation of S5 disrupts the electrostatic interaction between the PYDs of NLRP3 and ASC, 126 suggesting that phosphorylation of S5 prevents activation of the NLRP3 inflammasome at steady state.
Dephosphorylation of S5 requires phosphatase 2A, leading to the PYD-PYD interaction between NLRP3 and ASC. 126 Nitrosylation of NLRP3 has also been shown to regulate the NLRP3 inflammasome negatively. NLRP3-mediated IL-1 release and speck formation are inhibited in the presence of NO donor S-nitroso-N-acetlypenicillamine or S-nitrosoglutathione, which stabilizes damaged mitochondria and provides protection against LPS-induced endotoxemia. 127 Furthermore, it was reported that thiol nitrosylation of NLRP3 resulted in inhibition of IL-1 -mediated pathology in the context of M. tuberculosis infection. 128 An inhibitory property of the NO donor, S-nitroso-N-acetylpenicillamine, toward the NLRP3 inflammasome has also been reported. 129 
NONCANONICAL NLRP3 INFLAMMASOME
The noncanonical NLRP3 inflammasome pathway is defined by a requirement for caspase-11 in the activation of the NLRP3 inflammasome complex 133 ( Fig. 2B ). Gram-negative bacteria, including Citrobacter rodentium, Escherichia coli, Vibrio cholerae, Salmonella enterica serovar Typhimurium, Legionella pneumophila, and Yersinia pseudotuberculosis, are the major activators of the noncanonical NLRP3 inflammasome pathway. [133] [134] [135] [136] Caspase-11, a murine inflammatory caspase, senses LPS in the cytoplasm. 134, 137, 138 The human analogs of caspase-11, -4, and -5 can likewise sense LPS 138 and initiate activation of the NLRP3 inflammasome and secretion of IL-1 and IL-18. [139] [140] [141] Caspase-4, -5, and -11 bind to the lipid A portion of LPS with high specificity and affinity via their CARD. 138 Caspase-11 can also be activated by transfection or electroporation of LPS into macrophages. 133, 134, 137 Activated caspase-11 cannot directly proteolytically process pro-IL-1 and pro-IL-18 but can induce pyroptosis without caspase-1. 133 Pyroptosis mediated by caspase-11 provides effective host defense against cytosolic Gram-negative bacteria in vivo. 135, 142 The enzymatic activity of caspase-11, along with that of caspase-1, synergistically restricts the growth of intracellular Gram-negative bacteria in macrophages,
intestinal epithelial cells, and fibroblasts. [143] [144] [145] [146] [147] The mechanisms regulating the activation of the noncanonical NLRP3 inflammasome are still being deciphered. LPS that has gained entry into the cytoplasm activates inflammatory caspases, [133] [134] [135] 148 allowing them to cleave and release directly the N-terminal fragment of gasdermin D to drive pyroptosis (further discussed in GASDER-MIN below) [14] [15] [16] (Fig. 2B ). The gasdermin D N-terminal fragment also has a role in activating the NLRP3 inflammasome via an undefined mechanism. 14-16 Activation of caspase-11 leads to a drop in intracellular potassium levels sufficient to activate NLRP3, 149 highlighting that the noncanonical pathway might also have a dependency on potassium efflux. A further study has shed light on this issue and found that LPS-induced activation of caspase-11 leads to caspase-11-dependent cleavage of the large pore channel pannexin-1. 150 As a result, ATP is released from the cell, activating the purinergic receptor P2X7R to drive pyroptosis. 150 The opening of the pannexin-1 pore also generates potassium efflux that induces IL-1 release, 150 providing an explanation for how caspase-11 might activate the NLRP3 inflammasome kDa proteins conserved across species, with 7 GBPs in humans and 11 GBPs in mice. 155 In the context of inflammasome biology, GBPs encoded on mouse chromosome 3 (GBP1, -2, -3, -5, and -7) are required for activation of the noncanonical NLRP3 inflammasome induced by S. Typhimurium and L. pneumophila. 156, 157 GBPs are recruited to the vacuole surrounding the intracellular bacterial pathogens, where they facilitate lysis of the vacuolar membrane such that LPS is leaked into the cytoplasm for detection by caspase-11. 156 GBPs also direct IRGB10 to the cell membrane of Gram-negative bacteria to induce bacteriolysis, thereby increasing the cytosolic accessibility of LPS for detection by caspase-11. 158 There is also evidence to suggest that GBPs encoded on mouse chromosome 3 facilitate activation of both noncanonical and canonical inflammasomes in macrophages infected with Chlamydia muridarum. 159 In this case, GBPs bound neither the vacuole surrounding C. muridarum nor the pathogens, 159 suggesting an alternative mechanism of GBPs in the regulation of inflammasome activity.
Recent studies have suggested that caspase-11 can recognize ligands other than LPS. Caspase-11 binds to host-derived oxidized phospholipids (oxAPC) in activated DCs. 160 LPS and oxAPC elicit caspase-11-induced inflammasome speck formation and IL-1 release, but not pyroptosis, in DCs. 160 In addition, caspase-11 contributes to host resistance to the fungal pathogen Aspergillus fumigatus in vivo, 161 revealing a biologic role for caspase-11 in host defense against pathogens other than Gram-negative bacteria. Overall, substantial advances have been made in our understanding of the noncanonical NLRP3 inflammasome. It is likely that caspase-11 has the potential to recognize additional stimuli. Therefore, further studies are required to provide a more complete picture of the role of caspase-11 in infection and sterile inflammation.
GASDERMIN
The molecular mechanisms of how pyroptosis is executed following inflammasome activation are being revealed. 162 The current view is that inflammatory caspases cleave the pore-forming protein gasdermin D, yielding a 31 kDa N-terminal fragment that drives pyroptosis [14] [15] [16] (Fig. 2B) . The N-terminal fragment also engages activation of the NLRP3 inflammasome via an undefined mechanism. [14] [15] [16] Various studies have since identified a capacity for gasdermin D to oligomerize on the cell membrane. [17] [18] [19] [20] [21] The N-terminal fragment associates with the inner leaflet of the host cell membrane, where it forms pores of 10-21 nm in diameter. [17] [18] [19] [20] [21] These pores and/or the physical rupture of the cell allow passive release of proteolytically processed IL-1 and IL-18 into the extracellular space. [14] [15] [16] It is worthy to note that in some cases, release of IL-1 could occur before pyroptosis or even in the absence of pyroptosis. 163, 164 The N-terminal fragment of gasdermin D also binds to lipids on bacterial cell membranes, creating pores on the bacterial cell membrane as a mechanism to exert antimicrobial activity. 17, 19, 20 Previous studies have argued that the primary bactericidal mechanism of pyroptosis is its ability to liberate whole bacteria or bacteria entrapped within pore-induced intracellular traps, such that these entities are phagocytosed and killed by neutrophils. 143, 165 It would be important to investigate whether direct gasdermin D-induced killing of bacteria is a natural phenomenon that is executed within the host cell or outside of the cell.
Gasdermin D might also have functions in inhibiting apoptosis.
Canonical activation of the inflammasome induces apoptosis in the absence of gasdermin D. 16 It has also been suggested that in the absence of gasdermin D, induction of apoptosis requires caspase-1-mediated activation of caspase-3 and -7. 166 Site-specific cleavage of gasdermin D has been suggested to dictate the functionality of gasdermin D in pyroptosis and apoptosis. A recent study has shown that inhibition of serine peptidases DPP8 and DPP9 leads to activation of caspase-1, cleavage of gasdermin D, and pyroptosis. 167 However, in response to classic apoptotic signals, activated caspase-3 and -7 cleave gasdermin D at residue D87, a different site to that cleaved by inflammatory caspases. 166 The resultant p45 gasdermin D fragment is inactive and cannot engage pyroptosis, allowing apoptosis to ensue. 166 A related gasdermin member (gasdermin E) can also mediate cross-regulation between pyroptosis and apoptosis. HeLa cells expressing high levels of gasdermin E and stimulated with TNF or chemotherapeutic agents undergo caspase-3-mediated cleavage of gasdermin E at its linker region, generating an N-terminal fragment that perforates membrane and induces pyroptosis. 168 By contrast, HeLa cells expressing low levels of gasdermin E display apoptotic characteristics before pyroptotic morphology and lysis. Therefore, it is possible that a high-level expression of gasdermin E is required to enforce pyroptosis and over-ride the execution of apoptosis. These studies further highlight complex crosstalks between pyroptosis and apoptosis. The physiologic effects of gasdermin E have been elucidated in a mouse model. Wild-type mice injected with the chemotherapeutic drugs cisplatin, 5-fluorouracil, or bleomycin are susceptible to severe inflammation, tissue damage, infiltration of inflammatory cells, loss of crypts in the small intestine, and weight loss. 168 However, mice lacking gasdermin E are protected from these adverse effects,
suggesting that gasdermin E-mediated pyroptosis has a vital role in chemotherapy drug-induced toxicity. 168 These findings highlight the importance of gasdermin proteins in inflammation and immunity and identify new therapeutic targets for the treatment of inflammasomeassociated diseases.
NAIP-NLRC4 INFLAMMASOME
The NLRC4 inflammasome is activated by cytosolic flagellin [169] [170] [171] [172] [173] and by both the basal body rod 174, 175 and needle 176, 177 proteins of the T3SS of many Gram-negative bacteria (Fig. 3) . Other studies had
shown the role of a related NLR family member (Naip5) in sensing flagellin 172, [178] [179] [180] [181] and instigating host response to the intracellular pathogen L. pneumophila. [182] [183] [184] [185] Further studies have clarified the relationship between Naip proteins and NLRC4, showing that Naip proteins dictate the ligand specificity of the NLRC4 inflammasome. [186] [187] [188] [189] Of the 7 Naip proteins encoded by the mouse genome, 190 Naip1 and Naip2 recognize the needle and rod protein components of bacterial T3SS, respectively, [175] [176] [177] 186, 187 whereas both Naip5 and Naip6 recognize flagellin. 180, 186, 187 Analysis of chimeric Naip proteins mapped the ligand-binding site to the NBD 191 rather than the LRR domain, which was thought to be responsible for ligand recognition in most NLR family proteins. The functions of the remaining murine Naip proteins remain uncharacterized. Unlike mice, humans encode a single NAIP protein, which was initially thought to be functionally similar to murine Naip1 in that it binds directly to the needle protein of bacterial T3SS to activate the NLRC4 inflammasome. 176, 177 However, a later study has
shown that human NAIP might also recognize flagellin, 192 highlighting the functional versatility of human NAIP compared with its murine counterparts (Fig. 3) .
NLRC4 consists of an N-terminal CARD, a centrally located NBD, and a C-terminal LRR domain. 193 The CARD of NLRC4 can directly interact with the CARD of procaspase-1, generating an NLRC4-caspase-1 inflammasome complex that is sufficient to induce pyroptosis and processing of pro-IL-1 and -IL-18 in the absence of ASC. 8, 9, 174, [194] [195] [196] [197] However, the NLRC4-ASC-caspase-1 inflammasome has also been observed endogenously in macrophages, 10 highlighting the compositional diversity of the NLRC4 inflammasome (Fig.   3 ). In this case, ASC enhances proteolytic cleavage and release of IL-1 and IL-18. 8-10, [196] [197] [198] [199] The structures of monomeric or inactive NLRC4, 200 IL-1β IL-18 F I G U R E 3 NAIP-NLRC4 inflammasome. Pathogenic bacteria, such as S. Typhimurium, deliver effector proteins via the T3SS. This process leads to the injection of T3SS needle protein, inner rod protein, and flagellin into the cytoplasm for detection by mouse Naips or human NAIP. 176, 177, 186, 187, 192 Mouse Naips or human NAIP interact with NLRC4, inducing a conformational change in NLRC4 that catalyzes the recruitment of additional NLRC4 proteins to form a disc structure. [201] [202] [203] Phosphorylation of NLRC4 by the kinase Pkc downstream of ligand-NAIP interaction may contribute to full activation of the inflammasome. 204, 205 The NAIP-NLRC4 complex assembles a NAIP-NLRC4-caspase-1 inflammasome or a NAIP-NLRC4-ASC-caspase-1 inflammasome. 9,10, [169] [170] [171] 194, 196, 197 The NAIP-NLRC4-caspase-1 inflammasome cleaves gasdermin D, unleashing the N-terminal fragment of gasdermin D that mediates pyroptosis. Both the NAIP-NLRC4-caspase-1 and NAIP-NLRC4-ASC-caspase-1 inflammasomes induce caspase-1-dependent proteolytic cleavage of pro-IL-1 and -IL-18. The NAIP-NLRC4 inflammasome also induces caspase-8-dependent cell death 87, 212, 226, 227 NLRC4 showed that the LRR domain sterically occludes the NBD, 200 revealing an autoinhibitory function of the LRR domain. By contrast, the active structures of NLRC4, in complex with either Naip2 202, 203 or Naip5, 201 showed that NLRC4 undergoes a conformational change, exposing an oligomerization surface to which inactive NLRC4 subunits can be recruited and bind to form a "disc" structure.
Phosphorylation of NLRC4 at residue S533 by the kinase PKC was initially found to be critical for activation of the NLRC4 inflammasome in macrophages in response to S. Typhimurium infection or flagellin 204 (Fig. 3) . A further study found that phosphorylation of NLRC4 at residue S533 occurs independently of activation of Naip5 by flagellin. 205 This finding suggests that phosphorylation of NLRC4 at residue S533 and binding of Naip5 to its cognate ligand are unrelated events. A further study argued that activation of the NAIP-NLRC4
inflammasome in macrophages infected with either S. Typhimurium or Shigella flexneri was independent of PKC . 175 The The cooperativity between NLRC4 and other NLRs in inflammasome activation has also been observed in contexts other than infection.
For instance, mouse macrophages exposed to hyperosmotic stress produce IL-1 in a manner dependent on both NLRC4 and NLRP3 inflammasome activity. 207 Likewise, NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes in response to the DAMP lysophosphatidylcholine. 62 Finally, in a rodent model of stroke, the NLRC4 and AIM2 inflammasomes contribute to ischemic brain injury in a manner that required ASC but not NLRP3. 208 The biologic effect of NAIP-NLRC4 inflammasome activation varies with cell type. Unlike macrophages, which undergo rapid pyroptosis following activation of the NAIP-NLRC4 inflammasome, neutrophils release IL-1 without undergoing pyroptosis. 209 NLRC4 has also been shown to facilitate discrimination between commensal and pathogenic bacteria in the intestine by producing IL-1 in response to S. Typhimurium and Pseudomonas aeruginosa but not commensal bacteria. 213 Indeed, expression of NLRC4 in the intestinal epithelial cells of mice protects against infection by the enteric pathogen C. rodentium. 214 A further interesting biologic effect of the NAIP-NLRC4 inflammasome is its ability to sustain the level of the growth hormone insulin-like growth factor 1 in white adipose tissue to promote the protective effect of a commensal E. coli O21:H + strain against muscle wasting induced by the pathogenic bacteria Burkholderia thailandensis. 215 However, uncontrolled activation of the NAIP-NLRC4 inflammasome is detrimental and leads to systemic inflammation and rapid sepsis-like death in mice infected with an E. coli pathobiont. 216 Likewise, systemic activation of the NLRC4 inflammasome by flagellin leads to rapid production of inflammatory lipid eicosanoids, loss of vascular fluid, and death in mice. 217 As the NAIP-NLRC4 inflammasome is activated in response to specific bacterial ligands in the context of infection, it is possible that NAIP and NLRC4 may be activated differentially in response to other contextual cues. [218] [219] [220] [221] Indeed, mouse Naips have been proposed to have NLRC4-independent functions. 219 In this case, Naips might suppress the transcription factor STAT3 and cell proliferation in the intestinal epithelium in response to carcinogen exposure. 219 On the other hand, NLRC4 might function independently of Naips or the inflammasome during colorectal tumorigenesis through a mechanism that targets inhibition of apoptosis. 218 Furthermore, NLRC4
mediates the production of cytokines and chemokines in tumorassociated macrophages and induces the generation of protective T cell responses independently of the inflammasome in response to melanoma tumor growth. 221 Finally, the nucleotide metabolites adenine and N 4 -acetylcytidine have recently been shown to activate the NLRC4 inflammasome in elderly individuals and contribute to the development of arterial hypertension. 222 Additional studies are required to understand more fully the distinct molecular mechanisms governing NAIP and NLRC4 activation in conditions other than infectious diseases.
Several disease-association mutations of NLRC4 have been identified in humans and mice. Identification of these mutations has contributed to our understanding of the molecular mechanisms regulating activation of the NLRC4 inflammasome. Several gain-of-function missense mutations in the highly conserved NBD of NLRC4 have been observed, including V341A, 223 T337S, 224 and H443P. 225 Macrophages Indeed, the NLRC4 mutations mentioned previously cause severe autoinflammatory syndromes when present in humans. Carriers of NLRC4 mutant H443P develop a familial cold autoinflammatory syndrome. 225 Likewise, 2 activating missense mutations in NLRC4 (T337S and V341A) led to the development of severe enterocolitis 223 and recurrent macrophage activation syndrome, 224 respectively. All 3 cases were characterized by constitutive caspase-1 activation and by release of IL-1 and IL-18, indicating that the NLRC4 inflammasome was hyperactive in these patients. Of translational importance is that a patient suffering from a life-threatening macrophage activation syndrome caused by the NLRC4 mutation V341A was treated with recombinant human IL-18-binding proteins. 228 Within 4 d of the first treatment, the patient's overall demeanor improved, and the patient remains well after 11 mo of combined IL-1 and IL-18 blockade. 228 This case report provides an elegant example of how investigations into the molecular mechanisms controlling activation of NLRC4 could lead to therapeutic success in the treatment of human diseases.
AIM2 INFLAMMASOME
AIM2 is a cytoplasmic innate immune sensor of dsDNA, capable of forming an inflammasome complex with ASC and procaspase-1 [229] [230] [231] [232] ( Fig. 4) . AIM2 consists of a C-terminal dsDNA-binding HIN-200 domain and an N-terminal PYD. The dsDNA recognized by AIM2 is not sequence specific but must be at least 80 bp in length. 233 The crystal structure of AIM2 provides insight into the mechanism of activation of AIM2. In an inactive conformation, the HIN-200 domain of AIM2 interacts with the PYD in an autoinhibitory fashion. 234 The release of the AIM2 PYD upon binding dsDNA allows for oligomerization of AIM2 along the DNA 235 and interaction with the PYD of ASC. 233 Others have found that the PYD facilitates self-oligomerization of AIM2
and induces activation of the AIM2 inflammasome. 236, 237 Whereas AIM2 is constitutively expressed and maintained in an autoinhibitory conformation in resting cells, 238 other host-specific mechanisms exist to ensure tight regulation of the AIM2 inflammasome. AIM2 can be tagged for degradation by the regulatory protein TRIM11 and the autophagy-associated protein p62. 239, 240 Furthermore, several proteins that inhibit activation of the AIM2 inflammasome are also produced by the cell, including the PYD-containing proteins POP1 241 and POP3 242 in humans and the HIN domain-containing protein p202 in mice 232, [243] [244] [245] [246] (Fig. 4) . 159 Porphyromonas gingivalis, 259 and Brucella abortus, 260, 261 and the dsDNA viruses CMV and vaccinia virus. 248 The AIM2 inflammasome is also activated upon infection with the malaria parasite Plasmodium 262 and the fungal pathogen A. fumigatus. 109 The mechanism of AIM2 activation and its dependency on type I
IFNs differ depending on the pathogen encountered by the cell. Infection by murine CMV is sufficient to directly activate the AIM2 inflammasome in macrophages without a requirement for type I IFN signaling, a phenotype that is recapitulated by activation of the AIM2 inflammasome via transfection of naked dsDNA into the cytoplasm of macrophages. 263, 264 It is likely that viral DNA is directly exposed to AIM2 in the cytoplasm during infection with murine CMV. By contrast, type I IFN signaling is important for AIM2 inflammasome activation in response to intracellular bacterial pathogens. 159, 250, [264] [265] [266] [267] [268] The molecular mechanism underlying the differential requirement for IFN signaling between bacteria and viruses has begun to be unraveled (Fig. 4) . In Francisella infection, a small quantity of bacterial DNA is released that is sufficient to activate the DNA sensors cGAS, STING, and IFI204 and promote type I IFN production but not sufficient to activate AIM2. 238 
IL-1β IL-18
F I G U R E 4 AIM2 inflammasome. Certain cytosolic bacteria and DNA viruses and mammalian DNA can activate the AIM2 inflammasome. 238, 247, 248, 263 The cytosolic bacterium Francisella novicida induces the production of type I IFNs, 265 activating the type I IFN signaling pathway via the transcription factor IRF1. 264 IRF1 induces up-regulation of IFIs GBPs and IRGB10, 158, 264 where these proteins directly attack the bacterial membrane of F. novicida. 158, 264, 268 The ruptured bacteria release DNA into the cytoplasm. The DNA virus mouse CMV activates AIM2 independently of type I IFN signaling. Nuclear DNA from host cells that are exposed to ionizing radiation undergo dsDNA breakage. AIM2 and ASC redistribute to the nucleus, where the 2 inflammasome proteins localize to dsDNA breaks and -H2AX. 285 The AIM2-ASC complex moves to the cytoplasm to assemble an inflammasome complex. 285 Damage to the nuclear envelope caused by the HIV protease inhibitor Nelfinavir mediates the release of nuclear DNA. 286 AIM2 is normally maintained in an autoinhibitory state via interaction between its HIN-200 domain and the PYD. 233 On recognition of DNA, AIM2 assembles an inflammasome complex. AIM2 can be inhibited by a mouse p202, a bipartite protein containing 2 HIN domains that interact with the HIN domain of AIM2. 232, 245 AIM2 can also be inhibited by human POP1 and POP3 241, 242 inflammasome. The viral pathogen human CMV produces a tegument protein pUL83 that directly interacts with AIM2 to prevent inflammasome activation. 271 Interestingly, F. novicida encodes a Cas9-dependent clustered regularly interspaced short palindromic repeatsCas system that enhances envelope integrity, 272 Furthermore, mice deficient in AIM2 are protected from the radiationinduced gastrointestinal syndrome and hematopoietic failure. 285 Importantly, AIM2 relocates to the nucleus, where it colocalizes with the marker of dsDNA breaks, -H2AX, and assembles an inflammasome complex in macrophages exposed to ionizing radiation 285 ( Fig. 4) . Additionally, disruption of the nuclear envelope by an HIV aspartyl protease inhibitor, Nelfinavir, was found to activate the AIM2 inflammasome by releasing DNA into the cytosol. 286 A further study has shown that dsDNA, released from intestinal cells damaged by chemotherapy treatment, activates the AIM2 inflammasome in immune cells, leading to production of IL-1 and IL-18 and diarrhea. 287 In this case, abrogation of AIM2 signaling significantly reduced the incidence of diarrhea without affecting the anticancer effect of the chemotherapeutic. 287 A detrimental role of AIM2 in metastatic skin cancer has also been proposed. A study has suggested that knockdown of AIM2 resulted in reduced cancer cell viability, suppression of growth, and vascularization of xenografts in vivo and the onset of apoptosis. 288 DNA released from damaged or dying cells during infection could also lead to activation of the AIM2 inflammasome. For example, host-derived DNA molecules are liberated from virus-infected cells and accumulate in the lungs following infection by the RNA virus IAV. A study has shown that that AIM2-deficient mice infected with IAV exhibited attenuated lung injury and significantly improved survival compared with wild-type mice. 289 Another study, however, has reported that AIM2-deficient mice had increased susceptibility to IAV infection, owing to increased numbers of infiltrating leukocytes and an exaggerated immune response. 290 The strikingly different host susceptibility to infection by IAV observed in these 2 studies could be owing to the different source and infection dose of the virus, as well as differences in the microbiota composition at different animal facilities. Nevertheless, these findings collectively demonstrate that AIM2 can also function as a sensor of DAMPs in that it activates the inflammasome in response to self-DNA; however, activation of the AIM2 inflammasome in many of these cases leads to excessive cell death and tissue injury rather than a protective inflammatory response.
PYRIN INFLAMMASOME
Pyrin, encoded by the MEFV gene, is a member of the TRIM family. Mis- Earlier studies had suggested that Pyrin interacts with components of the NLRP3 inflammasome and that Pyrin inhibits the activation of caspase-1, NF-B, and apoptosis. 38,294-296 Further in vitro evidence demonstrates that Pyrin is an inflammasome-activating sensor (Fig. 5) . Genetic silencing of Pyrin using small interfering RNA reduced inflammasome activation in THP-1 cells infected with Burkholderia cenocepacia. 297 Genetic deletion of Pyrin also abolished inflammasome assembly, caspase-1 activation, and IL-1 and IL-18 secretion. 298 The activator of Pyrin was later identified as Rhoinactivating toxins produced by bacteria (Fig. 5) , including those from B. cenocepacia, Clostridium difficile, Clostridium botulinum, Vibrio parahemolyticus, and Histophilus somni. 298 These toxins inactivate
RhoA at the GTPase switch-I region, leading to activation of the Pyrin inflammasome. 298 In addition, the pertussis toxin was found to engage activation of the Pyrin inflammasome in a manner dependent on the ADP-ribosyltransferase activity of the toxin. 299 Furthermore,
Pyrin contributed to pertussis toxin-induced neutrophil adhesion to IL-1β IL-18 F I G U R E 5 Pyrin inflammasome. During homeostasis, Pyrin is phosphorylated by RhoA effectors and serine-threonine kinases PKN1 and PKN2. 259 Phosphorylated Pyrin is bound by 14-3-3 proteins, inducing inhibition of Pyrin. 302, 303 Certain bacteria secrete toxins that inactivate RhoA, a process that mediates dephosphorylation of Pyrin. [298] [299] [300] Mutations in certain sites of Pyrin also lead to dephosphorylation of Pyrin. 304, 305 This dephosphorylation event triggers Pyrin dissociation from 14-3-3 proteins, unleashing active Pyrin that is then capable of assembling an inflammasome complex 298 cerebral capillaries and the induction of experimental autoimmune encephalomyelitis in mice. 299 The expression of Pyrin is up-regulated following TLR priming of mouse BMDMs. 300 Whereas not necessary, TLR-dependent priming enhances activation of the Pyrin inflammasome by the C. difficile toxins TcdA and TcdB. 300 The role of Pyrin inflammasome in the host defense against infection has been demonstrated in a mouse model of lethal GTPases to activate the Pyrin inflammasome, induces lethality in wildtype mice more rapidly than did a wild-type B. cenocepacia strain. 301 These findings collectively demonstrate that the Pyrin inflammasome mediates recognition of Rho deamidase activity of TecA in B. cenocepacia to drive protective responses in the host.
Human Pyrin was previously found to interact with 2 isoforms of the regulatory proteins, known as 14-3-3 and 14-3-3 . 302 A further study has shown that Pyrin interacts with all 7 isoforms of 14-3-3 proteins in mouse BMDMs. 303 Phosphorylation of Pyrin at sites S208, S209, and S242 is necessary to mediate interaction with 14-3-3 proteins. 302 Further mechanistic studies have unraveled the biologic significance of the interaction between Pyrin and 14-3-3
proteins. A mutation in the MEFV gene that causes a S242R substitution abolishes inhibitory binding of 14-3-3 proteins to Pyrin. 304 This mutation was found in patients with a newly described autoinflammatory condition called PAAND. 304 The S242R mutation promotes excessive ASC speck formation and activation of caspase-1 and secretion of IL-1 in 293T cells or in THP-1 monocytic cells. 304 Likewise, monocytes from patients with PAAND carrying the S242R mutation undergo spontaneous inflammasome activation in response to LPS stimulation. 304 Studies in the murine system have revealed that mouse Pyrin can be phosphorylated on S205 and S241-2 sites corresponding to S208
and S242 of human Pyrin, respectively 303 (Fig. 5) . The 2 serines are dephosphorylated in response to stimulation by Rho-inactivating toxins and infection with B. cenocepacia, releasing Pyrin from 14-3-3
proteins. 304 A further study has demonstrated that Pyrin is phosphorylated by the RhoA effector serine-threonine kinases PKN1 and PKN2. 305 Phosphorylation of human Pyrin at sites S208 and S242 by PKN1 or PKN2 promotes interaction between Pyrin and 14-3-3 or 14-3-3 proteins, thereby maintaining inhibition of the Pyrin inflammasome in unstimulated cells. 305 The presence of FMF-or PAANDassociated mutations in Pyrin impairs binding of Pyrin with 14-3-3 or PKN proteins. 304, 305 These findings provide an additional mechanistic insight into why patients carrying these mutations exhibit uncontrolled inflammasome responses.
Pharmacological drugs that target the microtubule, including colchicine, vinblastine, paclitaxel, BAL27862, nocodazole, ABT-751, CA4P, and CYT997, have all been reported to inhibit assembly and activation of the Pyrin inflammasome induced by TcdA or TcdB. 300, 303, 305 However, these microtubule inhibitors do not interfere with the dephosphorylation of Pyrin or dissociation of 14-3-3 proteins, 303 The relationship between Pyrin and other components of the cell has been identified. Human Pyrin was found to associate with the autophagy-related proteins ULK1, Beclin 1, and ATL16L1. 308 The same study also reported that Pyrin, but not Pyrin carrying FMFassociated mutations on the B30.2 domain, mediates recruitment of ULK1 to the NLRP3 inflammasome, where this complex is degraded by the autophagy machinery. 308 6. Cai, X., Chen, J., Xu, H., Liu, S., Jiang, Q.-X., Halfmann, R., Chen, Z. 91. Antonopoulos, C., Russo, H. M., El Sanadi, C., Martin, B. N., Li, X., Kaiser, W. J., Mocarski, E. S., Dubyak, G. R. 
